C-Ray Therapeutics Deal History & Licensing Activity
C-Ray Therapeutics is a large biotech headquartered in US. The company currently has 1 active clinical trial, primarily in Solid Tumors.
Deals (12mo)
2
Active Trials
1
Top Modality
N/A
Focus Area
Solid Tumors
C-Ray Therapeutics Pipeline Focus
Therapeutic areas and modalities where C-Ray Therapeutics is most active based on deal history and clinical trial data.
Therapeutic Areas
C-Ray Therapeutics Clinical Pipeline
C-Ray Therapeutics has 1 active clinical trial across 1 development phase.
1
Phase 1
See How Your Asset Matches C-Ray Therapeutics's Portfolio
Use Solidus to benchmark upfront payments, milestones, and royalties for Solid Tumors assets — powered by data from 3,500+ real biopharma transactions.
Related Intelligence
About C-Ray Therapeutics Licensing & Deal Activity
C-Ray Therapeutics is a large biotech company based in US that has been actively engaged in licensing transactions across the biopharma landscape.
Key therapeutic areas of focus for C-Ray Therapeutics include Solid Tumors (1 deal and trial).
Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for C-Ray Therapeutics and 850+ other biopharma companies. Use our Solidus to benchmark your asset against C-Ray Therapeutics's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.